Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Mark J. Smyth, Nicola Waddell et al.|Nature Immunology|2017Cited by 639
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor MicroenvironmentArabella Young, Mark J. Smyth, Shin Foong Ngiow et al.|Cancer Research|2017Cited by 378
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Mark J. Smyth, Achim K. Moesta et al.|Cancer Discovery|2019Cited by 269
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT DysregulationMarie‐Claude Gingras, Richard A. Gibbs, Kyle R. Covington et al.|Cell Reports|2016Cited by 149